论文信息 - Switching from one infliximab biosimilar (CT‐P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis - 字舞流文

Switching from one infliximab biosimilar (CT‐P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis

P. Gisondi | G. Girolomoni | S. Piaserico | A. Conti | G. Odorici | C. Virga | A. Meneguzzo